These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 2201581)

  • 1. [Polycystic ovary syndrome: a hypothalamic or a gonadal anomaly?].
    Ayala-Ruíz A; Valenzuela S
    Gac Med Mex; 1990; 126(2):108-13. PubMed ID: 2201581
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mechanisms of hypothalamic-pituitary-gonadal disruption in polycystic ovarian syndrome.
    Barontini M; García-Rudaz MC; Veldhuis JD
    Arch Med Res; 2001; 32(6):544-52. PubMed ID: 11750729
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Roles of Hypothalamic-Pituitary-Adrenal Axis and Hypothalamus-Pituitary-Ovary Axis in the Abnormal Endocrine Functions in Patients with Polycystic Ovary Syndrome.
    Wang F; Zhang ZH; Xiao KZ; Wang ZC
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2017 Oct; 39(5):699-704. PubMed ID: 29125115
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hypothesis: aberrant puberty and the Stein-Leventhal syndrome.
    Mechanick JI; Futterweit W
    Int J Fertil; 1984; 29(1):35-8. PubMed ID: 6146582
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Endocrinological environment in polycystic ovarian disease (PCOD)].
    Fujimoto S; Tanaka T
    Nihon Sanka Fujinka Gakkai Zasshi; 1988 Sep; 40(9):1465-70. PubMed ID: 3049852
    [No Abstract]   [Full Text] [Related]  

  • 6. Disruption of the synchronous secretion of leptin, LH, and ovarian androgens in nonobese adolescents with the polycystic ovarian syndrome.
    Veldhuis JD; Pincus SM; Garcia-Rudaz MC; Ropelato MG; Escobar ME; Barontini M
    J Clin Endocrinol Metab; 2001 Aug; 86(8):3772-8. PubMed ID: 11502810
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Regulation of gonadotropin secretion: implications for polycystic ovary syndrome.
    McCartney CR; Eagleson CA; Marshall JC
    Semin Reprod Med; 2002 Nov; 20(4):317-26. PubMed ID: 12536355
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Can polycystic ovary syndrome exist without concomitant hypothalamic dysfunction?
    Berga SL; Daniels TL
    Semin Reprod Endocrinol; 1997 May; 15(2):169-75. PubMed ID: 9165660
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dynamics of plasma gonadotropin and sex steroid release in polycystic ovarian disease after pituitary-ovarian inhibition with an analog of gonadotropin-releasing hormone.
    Calogero AE; Macchi M; Montanini V; Mongioi A; Maugeri G; Vicari E; Coniglione F; Sipione C; D'Agata R
    J Clin Endocrinol Metab; 1987 May; 64(5):980-5. PubMed ID: 3104389
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Polycystic ovary syndrome (author's transl)].
    Lecomte P; Kuttenn F; Mauvais-Jarvis P
    Nouv Presse Med; 1978 Feb; 7(5):355-6, 361-2. PubMed ID: 345233
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pituitary-ovarian responses to nafarelin testing in the polycystic ovary syndrome.
    Barnes RB; Rosenfield RL; Burstein S; Ehrmann DA
    N Engl J Med; 1989 Mar; 320(9):559-65. PubMed ID: 2521688
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Recovery of hormone secretion after chronic gonadotropin-releasing hormone agonist administration in women with polycystic ovarian disease.
    de Ziegler D; Steingold K; Cedars M; Lu JK; Meldrum DR; Judd HL; Chang RJ
    J Clin Endocrinol Metab; 1989 Jun; 68(6):1111-7. PubMed ID: 2524501
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Disorders of the hypothalamic-pituitary-ovarian axis.
    Baird DT; Fraser IS
    Clin Endocrinol Metab; 1973 Nov; 2(3):469-88. PubMed ID: 4591139
    [No Abstract]   [Full Text] [Related]  

  • 14. The effects of ovarian wedge resection on circulating gonadotropin and ovarian steroid levels in patients with polycystic ovary syndrome.
    Judd HL; Rigg LA; Anderson DC; Yen SS
    J Clin Endocrinol Metab; 1976 Aug; 43(2):347-55. PubMed ID: 950366
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Polycystic ovary syndrome of extra-ovarian origin. Review].
    Terán Dávila J; Teppa-Garrán AD
    Invest Clin; 2001 Mar; 42(1):51-78. PubMed ID: 11294032
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Polycystic ovary syndrome.
    Siegel SF; Lee PA
    Curr Opin Pediatr; 1993 Aug; 5(4):400-6. PubMed ID: 8374664
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Do androgens directly regulate gonadotropin secretion in the polycystic ovary syndrome?
    Dunaif A
    J Clin Endocrinol Metab; 1986 Jul; 63(1):215-21. PubMed ID: 3086357
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pituitary-ovarian response to the gonadotrophin-releasing hormone-agonist test in anovulatory patients with polycystic ovary syndrome: predictive role of ovarian stroma.
    Fulghesu AM; Angioni S; Belosi C; Apa R; Selvaggi L; Ciampelli M; Iuculano A; Melis GB; Lanzone A
    Clin Endocrinol (Oxf); 2006 Sep; 65(3):396-401. PubMed ID: 16918963
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The pathophysiology of polycystic ovary syndrome: trying to understand PCOS and its endocrinology.
    Balen A
    Best Pract Res Clin Obstet Gynaecol; 2004 Oct; 18(5):685-706. PubMed ID: 15380141
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neuroendocrine effects of androgens in adult polycystic ovary syndrome and female puberty.
    Blank SK; McCartney CR; Helm KD; Marshall JC
    Semin Reprod Med; 2007 Sep; 25(5):352-9. PubMed ID: 17710731
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.